On Wednesday, July 12 the FDA's Oncologic Drugs Advisory Committee convened at a meeting to discuss the pending approval of CAR-T cell therapy CTL019. Our co-founders were present at the meeting, and Tom Whitehead spoke.
On Friday, July 14 we held our third annual "Tee Off for T-Cells" charity golf tournament at Philipsburg Elks Lodge & Country Club in Philipsburg, Pa. In the last three years, "Tee Off for T-Cells" has now raised more than $150,000 for pediatric cancer research.
Emily Whitehead Foundation co-founder Tom Whitehead has been accepted as a speaker for the Oncologic Drugs Advisory Committee (ODAC) meeting on July 12, 2017. At this hearing, the U.S. Food & Drug Association (FDA) will discuss the pending approval of CAR-T cell therapy CTL019.
We celebrated an incredible milestone this month — on May 10, 2017 Emily reached five years cancer free! In acknowledgement, our co-founders discussed this milestone anniversary, the opportunities they have been blessed to experience, and the impact of the Emily Whitehead Foundation in an interview with The Philadelphia Inquirer.
To many, Emily is a hero. Today, as she celebrates 5 years cancer free after T-cell therapy, Emily shares who her hero is—her mom and Emily Whitehead Foundation co-founder Kari Whitehead. Watch Kari's Modern Hero story!
On May 9-10, 2017, the Emily Whitehead Foundation will participate in Centre Gives, a 36-hour online annual giving event sponsored by the Centre Foundation. Emily will be 5 years cancer free on May 10! In honor of this, we hope you will join us in extending the same community support that Emily received to more children fighting cancer.